CDK5 and Alzheimer disease: In addition, CDK5 is highly expressed in the brains of patients with AD, and genetic overexpression of CDK5 or increased CDK5 activity induces NFT formation, synaptic damage, and neuronal death in vitro and in vivo (58, 59).